APA (7th ed.) Citation

Wojenski, D., Bartoo, G., Merten, J., Dierkhising, R., Barajas, M., el‐Azhary, R., . . . Hashmi, S. (2015). Voriconazole exposure and the risk of cutaneous squamous cell carcinoma in allogeneic hematopoietic stem cell transplant patients. Transplant Infectious Disease, 17(2), 250. https://doi.org/10.1111/tid.12367

Chicago Style (17th ed.) Citation

Wojenski, D.J, et al. "Voriconazole Exposure and the Risk of Cutaneous Squamous Cell Carcinoma in Allogeneic Hematopoietic Stem Cell Transplant Patients." Transplant Infectious Disease 17, no. 2 (2015): 250. https://doi.org/10.1111/tid.12367.

MLA (9th ed.) Citation

Wojenski, D.J, et al. "Voriconazole Exposure and the Risk of Cutaneous Squamous Cell Carcinoma in Allogeneic Hematopoietic Stem Cell Transplant Patients." Transplant Infectious Disease, vol. 17, no. 2, 2015, p. 250, https://doi.org/10.1111/tid.12367.